Incontinence News and Research

Latest Incontinence News and Research

Shunting may not ward off poor hydrocephalus cognitive outcomes

Around half of patients with idiopathic normal-pressure hydrocephalus will develop dementia, despite responding to shunting, study findings suggest.

19 Oct 2012

LRRK2 inhibitors may provide neuroprotection for patients with Parkinson's

For decades, patients with Parkinson's disease (PD) have had the same experience. Their hands start to shake uncontrollably, their limbs become rigid and they lose their balance. Years before those movement problems set in, many begin struggling with fainting, incontinence, sexual dysfunction, anxiety and depression. Many patients are still treated with a 42-year-old drug called L-DOPA, which temporarily staves off symptoms but can itself cause heart arrhythmias, stomach bleeding and hallucinations.

16 Oct 2012

Zero out of TEN for fecal incontinence treatment

Transcutaneous electrical nerve stimulation is no more effective than placebo for the treatment of fecal incontinence, say French researchers.

10 Oct 2012

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Working with individuals with traumatic brain injury (TBI) every day, I see the debilitating effects and long-term struggles firsthand.

9 Oct 2012

Oral medication as effective as Botox injections for treating incontinence in women

Oral medication for treating a type of incontinence in women is roughly as effective as Botox injections to the bladder, reported researchers who conducted a National Institutes of Health clinical trials network study, with each form of treatment having benefits and limitations.

6 Oct 2012

Botox injections effectively treat urinary urgency incontinence in women

Botox- (onabotulinum toxin-A) injections to the bladder are as effective as medication for treating urinary urgency incontinence in women, but the injection is twice as likely to completely resolve symptoms. These findings were published in the latest issue of The New England Journal of Medicine by a National Institutes of Health clinical trials network including Loyola University Chicago Stritch School of Medicine (SSOM).

5 Oct 2012

Loyola researchers to study link between long-distance running and pelvic floor disorders

While many marathon runners may be preoccupied with shin splints, chafing and blisters come race day, one thing they may not consider is their bladder health.

5 Oct 2012

ConvaTec acquires 180 Medical

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has completed the acquisition of 180 Medical Holdings, Inc.

29 Sep 2012

Loyola now offers sacral nerve stimulation for patients with fecal incontinence

Fecal incontinence, or the inability to control the bowels, is a highly underreported and stigmatized condition, according to colorectal surgeons at Loyola University Health System (LUHS).

27 Sep 2012

Fecal incontinence remains a problem after laparoscopic surgery

Fecal incontinence improves after surgery for rectal prolapse, but research shows that the degree of improvement is quite low.

19 Sep 2012

Many women undertreat pelvic floor disorders and suffer in silence

New research issued by the PFD Alliance finds that 90 percent of Americans underestimate or are unsure about the prevalence of pelvic floor disorders (PFDs) which will impact one in three women at some point during their lives. This means many women undertreat PFDs and suffer in silence.

19 Sep 2012

Thalidomide effective in treating disabling cough among people with idiopathic pulmonary fibrosis

In the first clinical trial to demonstrate an effective treatment for constant, disabling cough among people with idiopathic pulmonary fibrosis (IPF), researchers at the Johns Hopkins University School of Medicine found that taking thalidomide significantly reduced the cough and improved quality of life.

18 Sep 2012

Antimuscarinics only moderately effective for overactive bladder

A comprehensive review of oral antimuscarinics for the treatment of overactive bladder concludes that the efficacy of treatment is, at best, moderate.

17 Sep 2012

U-M develops new guidelines for family physicians to evaluate urinary leakage in women

Millions of women experience a loss of bladder control, or urinary incontinence, in their lifetime. It's a common and often embarrassing problem that many patients don't bring up with their doctors - and when they do, it may be mentioned as a casual side note during a visit for more pressing medical issues.

14 Sep 2012

GE Healthcare announces data from [18F]flutemetamol phase III studies on Alzheimer's

GE Healthcare today announced pooled results from phase III brain autopsy and biopsy studies on the investigational PET amyloid imaging agent, [18F]flutemetamol, which showed a strong concordance between [18F]flutemetamol images and Alzheimer's disease-associated beta amyloid brain pathology.

11 Sep 2012

Pfizer, Mylan enter settlement agreement to resolve generic Detrol LA litigation

Mylan Inc. today announced that it and its subsidiary, Mylan Pharmaceuticals Inc., have entered into a settlement agreement with Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB that will resolve the parties' patent litigation in connection with Mylan Pharmaceuticals' Abbreviated New Drug Application (ANDA) for Tolterodine Tartrate ER capsules, 2 mg and 4 mg, which is the generic version of Pfizer's Detrol LA, indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

7 Sep 2012

Targacept plans to pursue development of TC-5214 for overactive bladder

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that it plans to pursue development of TC-5214 as a treatment for overactive bladder (OAB).

6 Sep 2012

Kinetic Concepts launches Skin IQ 1000 MCM to help prevent and treat stage I-IV pressure ulcers

Kinetic Concepts, Inc. (KCI) announced today the U.S. launch of the Skin IQ 1000 Microclimate Manager (MCM) by its Therapeutic Support Systems (TSS) business.

6 Sep 2012

Sacral neuromodulation cost-effective for fecal incontinence

Sacral neuromodulation is less costly than dynamic graciloplasty and artificial bowel sphincter for the treatment of fecal incontinence, show the results of a Dutch health economics study.

5 Sep 2012

Nottingham scientists develop novel antimicrobial catheter

A novel antimicrobial catheter that remains infection-free for up to twelve weeks could dramatically improve the lives of long-term catheter users. The scientists who have developed the new technology are presenting their work at the Society for General Microbiology's Autumn Conference at the University of Warwick.

4 Sep 2012

Incontinence News and Research

Latest Incontinence News and Research

Shunting may not ward off poor hydrocephalus cognitive outcomes

LRRK2 inhibitors may provide neuroprotection for patients with Parkinson's

Zero out of TEN for fecal incontinence treatment

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Oral medication as effective as Botox injections for treating incontinence in women

Botox injections effectively treat urinary urgency incontinence in women

Loyola researchers to study link between long-distance running and pelvic floor disorders

ConvaTec acquires 180 Medical

Loyola now offers sacral nerve stimulation for patients with fecal incontinence

Fecal incontinence remains a problem after laparoscopic surgery

Many women undertreat pelvic floor disorders and suffer in silence

Thalidomide effective in treating disabling cough among people with idiopathic pulmonary fibrosis

Antimuscarinics only moderately effective for overactive bladder

U-M develops new guidelines for family physicians to evaluate urinary leakage in women

GE Healthcare announces data from [18F]flutemetamol phase III studies on Alzheimer's

Pfizer, Mylan enter settlement agreement to resolve generic Detrol LA litigation

Targacept plans to pursue development of TC-5214 for overactive bladder

Kinetic Concepts launches Skin IQ 1000 MCM to help prevent and treat stage I-IV pressure ulcers

Sacral neuromodulation cost-effective for fecal incontinence

Nottingham scientists develop novel antimicrobial catheter

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Incontinence News and Research

Latest Incontinence News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in